THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (80K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 6/29/2022ACC: 0001493152-22-018110
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-80K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−50K
Price / share
—
Trade value
—
% of position
0.0%
6/27/2022
202.24M→202.19M
Common Stock
Direct
Shares
−30K
Price / share
—
Trade value
—
% of position
0.0%
6/28/2022
202.19M→202.16M
Total
Net shares
−80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2022 | S · Sale | −50K | — | — | 0.0% | 202.24M | 202.19M |
| Common Stock Direct | 6/28/2022 | S · Sale | −30K | — | — | 0.0% | 202.19M | 202.16M |
| Total | −80K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported